Friday, August 31, 2018 7:57:48 PM
Here is where it is now
PRECISION THERAPEUTICS INC - AIPT
Date: 2018-08-29 Fee: 103.5%
Date: 2018-08-29 Available: 80,000
Recent Data
Fee Available Updated
102.8 % 70,000 2018-08-31 17:45:02
102.8 % 70,000 2018-08-31 17:30:03
102.8 % 70,000 2018-08-31 17:15:03
102.8 % 70,000 2018-08-31 17:00:03
102.8 % 70,000 2018-08-31 16:45:02
And yesterday:
102.7 % 150,000 2018-08-30 13:15:02
102.7 % 150,000 2018-08-30 13:00:03
102.7 % 150,000 2018-08-30 12:45:02
102.7 % 150,000 2018-08-30 12:30:03
102.7 % 150,000 2018-08-30 12:15:03
103.4 % 150,000 2018-08-30 12:00:03
103.4 % 150,000 2018-08-30 11:45:02
That is IB data that anyone can check here live https://iborrowdesk.com/report/AIPT
That is why AIPT has one of the highest borrow rates of any stock and is on the Hard to Borrow List. Most stocks are 1-3% borrow rate, AIPT is 102% today. Even famous heavily shorted TSLA is only 1.8%
Recent Data (TSLA)
Fee Available Updated
1.8 % 350,000 2018-08-31 17:45:02
1.8 % 350,000 2018-08-31 17:30:03
1.8 % 350,000 2018-08-31 17:15:03
1.8 % 350,000 2018-08-31 17:00:03
https://iborrowdesk.com/report/tsla
So why would you say the opposite of the truth? You have an agenda which is easy to see.
Those are the facts and you said: "that's 106% false...also, negligible short interest, irrelevant. 70,000 available at IB if anyone is interested (I wouldn't recommend it, but don't like to short), standard rates apply, nothing out of the ordinary, no shortage of shares available thanks to ongoing perpetual dilution..."
How can you expect to have any credibility when you say the opposite of the truth when it is so easy to verify the truth?
Recent POAI News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 10:00:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 10:00:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/07/2023 01:54:30 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/05/2023 09:15:47 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 10:16:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2023 09:06:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2023 09:06:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2023 09:05:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2023 09:03:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2023 09:03:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/27/2023 10:25:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/17/2023 08:02:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 09:16:03 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 09:11:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 01:05:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 01:04:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 01:03:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 01:02:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 01:01:26 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM